...
首页> 外文期刊>Genetic Vaccines and Therapy >The significance of controlled conditions in lentiviral vector titration and in the use of multiplicity of infection (MOI) for predicting gene transfer events
【24h】

The significance of controlled conditions in lentiviral vector titration and in the use of multiplicity of infection (MOI) for predicting gene transfer events

机译:慢病毒载体滴定中控制条件的重要性以及感染复数(MOI)在预测基因转移事件中的应用意义

获取原文
           

摘要

Background Although lentiviral vectors have been widely used for in vitro and in vivo gene therapy researches, there have been few studies systematically examining various conditions that may affect the determination of the number of viable vector particles in a vector preparation and the use of Multiplicity of Infection (MOI) as a parameter for the prediction of gene transfer events. Methods Lentiviral vectors encoding a marker gene were packaged and supernatants concentrated. The number of viable vector particles was determined by in vitro transduction and fluorescent microscopy and FACs analyses. Various factors that may affect the transduction process, such as vector inoculum volume, target cell number and type, vector decay, variable vector – target cell contact and adsorption periods were studied. MOI between 0–32 was assessed on commonly used cell lines as well as a new cell line. Results We demonstrated that the resulting values of lentiviral vector titre varied with changes of conditions in the transduction process, including inoculum volume of the vector, the type and number of target cells, vector stability and the length of period of the vector adsorption to target cells. Vector inoculum and the number of target cells determine the frequencies of gene transfer event, although not proportionally. Vector exposure time to target cells also influenced transduction results. Varying these parameters resulted in a greater than 50-fold differences in the vector titre from the same vector stock. Commonly used cell lines in vector titration were less sensitive to lentiviral vector-mediated gene transfer than a new cell line, FRL 19. Within 0–32 of MOI used transducing four different cell lines, the higher the MOI applied, the higher the efficiency of gene transfer obtained. Conclusion Several variables in the transduction process affected in in vitro vector titration and resulted in vastly different values from the same vector stock, thus complicating the use of MOI for predicting gene transfer events. Commonly used target cell lines underestimated vector titre. However, within a certain range of MOI, it is possible that, if strictly controlled conditions are observed in the vector titration process, including the use of a sensitive cell line, such as FRL 19 for vector titration, lentivector-mediated gene transfer events could be predicted.
机译:背景技术尽管慢病毒载体已被广泛用于体外和体内基因治疗研究,但很少有系统地检查可能影响确定载体制剂中活载体颗粒数量的确定以及感染多重性使用的条件的研究。 (MOI)作为预测基因转移事件的参数。方法包装编码标记基因的慢病毒载体,浓缩上清液。通过体外转导,荧光显微镜和FAC分析确定了可行的载体颗粒的数量。研究了可能影响转导过程的多种因素,例如载体接种量,靶细胞数量和类型,载体衰变,可变的载体-靶细胞接触和吸附时间。常用细胞系和新细胞系的MOI在0到32之间。结果我们证明慢病毒载体滴度的最终值随转导过程中条件的变化而变化,包括载体的接种量,靶细胞的类型和数量,载体的稳定性以及载体对靶细胞的吸附时间长短。载体接种物和靶细胞数量决定了基因转移事件的发生频率,尽管不是成比例的。靶细胞的载体暴露时间也影响转导结果。改变这些参数会导致同一载体的载体效价差异大于50倍。载体滴定中常用的细胞系对慢病毒载体介导的基因转移的敏感性要低于新细胞系FRL19。在MOI的0-32之间,使用了转导四种不同细胞系的MOI越高,MOI的效率就越高。获得基因转移。结论转导过程中的几个变量影响了体外载体滴定,并导致与同一载体原种有极大不同的值,从而使MOI用于预测基因转移事件变得复杂。常用的靶细胞系低估了载体的效价。但是,在一定的MOI范围内,如果在载体滴定过程中观察到严格控制的条件,包括使用敏感细胞系(例如FRL 19)进行载体滴定,则慢载体介导的基因转移可能会发生。被预测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号